Benefits of successful percutaneous coronary intervention in chronic total occlusion patients with diabetes

Table 6 Comparison of changes in SAQ subscales from baseline to follow-up

	SAQ-PL	SAQ-AS	SAQ-AF	SAQ-TS	SAQ-DP
No Diabetes
Baseline	63.49 ± 14.59	50.23 ± 17.19	78.86 ± 24.38	79.93 ± 14.78	69.58 ± 18.74
1 month follow-up	69.12 ± 12.98	70.78 ± 23.97	97.93 ± 7.86	83.47 ± 11.56	72.31 ± 13.83
1 year follow-up	67.78 ± 11.95	71.95 ± 27.15	94.15 ± 11.21	86.65 ± 10.54	78.73 ± 15.62
^mΔ	5.46 ± 19.02	20.74 ± 30.16	19.56 ± 24.99	3.34 ± 16.45	2.90 ± 21.52
^yΔ	4.69 ± 17.89	20.00 ± 32.68	16.48 ± 25.91	6.26 ± 18.37	9.47 ± 25.16
^mp Value	< 0.001	< 0.001	< 0.001	< 0.001	0.005
^yp Value	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001
Diabetes
Baseline	61.72 ± 16.10	50.00 ± 15.08	76.67 ± 26.07	80.25 ± 15.47	70.54 ± 19.01
1 month follow-up	67.33 ± 14.45	72.90 ± 23.87	98.26 ± 7.07	84.16 ± 11.09	71.22 ± 14.18
1 year follow-up	66.68 ± 14.04	70.09 ± 29.03	94.61 ± 11.88	87.08 ± 9.31	78.51 ± 16.04
^mΔ	5.31 ± 20.37	22.98 ± 27.69	22.02 ± 26.32	3.76 ± 17.82	0.98 ± 22.74
^yΔ	5.46 ± 18.78	20.00 ± 32.68	20.04 ± 29.83	6.53 ± 19.31	8.30 ± 26.45
^mp Value	< 0.001	< 0.001	< 0.001	< 0.001	0.617
^yp Value	< 0.001	< 0.001	< 0.001	< 0.001	< 0.001
^ap Value	0.911	0.267	0.161	0.715	0.206
^bp Value	0.562	0.389	0.076	0.843	0.534

SAQ seattle angina questionnaire, SAQ-PL seattle angina questionnaire-physical limitation, SAQ-AS seattle angina questionnaire-anginal stability, SAQ-AF seattle angina questionnaire-anginal frequency, SAQ-TS seattle angina questionnaire-treatment satisfaction, SAQ-DP seattle angina questionnaire-disease perception
^mΔ change between baseline and 1 month follow-up
^yΔ change between baseline and 1 year follow-up
^mp Value: baseline versus 1 month follow-up
^yp Value: baseline versus 1 year follow-up
^ap Value: comparison of ^mΔ in the two groups
^bp Value: comparison of ^yΔ in the two groups

ISSN: 1475-2840